Skip to main content
ML

Microba Life Sciences

Microba Life Sciences utilizes advanced microbiome analysis and a unique databank to identify therapeutic leads for chronic diseases. Their technology addresses the need for precise diagnostics and targeted treatments by enhancing our understanding of the gut microbiome's role in human health.

Brisbane, AustraliaFounded 20179410K+ followers
Updated 20 months ago

Funding

$11.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

SH
Funding rounds are not available yet.

Founders

Product

Problem

Current diagnostic methods for gastrointestinal issues often lack the precision needed to identify specific microbial imbalances. This can lead to ineffective treatments and a limited understanding of the gut microbiome's role in chronic diseases. There is a need for more advanced and data-driven approaches to analyze the microbiome and develop targeted therapies.

Solution

Microba Life Sciences offers a comprehensive microbiome analysis platform that provides detailed insights into the gut microbiome's composition and function. Their technology utilizes a unique databank to identify potential therapeutic leads for chronic diseases. By combining advanced sequencing techniques with a proprietary data analysis pipeline, Microba enables precise diagnostics and facilitates the development of targeted treatments. The platform's end-to-end solution supports specialists, clinicians, and patients in understanding and modifying the microbiome to improve health outcomes.

Target Audience

Microba's primary customers include specialists, clinicians, and patients seeking advanced gastrointestinal diagnostics, as well as pharmaceutical companies and research institutions developing microbiome-based therapeutics.

Features

  • End-to-end microbiome analysis platform for comprehensive assessment of gut health
  • Unique databank for microbiome discovery, facilitating the identification of novel therapeutic targets
  • Advanced sequencing techniques to provide detailed insights into microbial composition and function
  • Proprietary data analysis pipeline for precise diagnostics and personalized treatment strategies
  • MetaPanel™ product for healthcare professionals, enabling advanced gastrointestinal diagnostics
  • Therapeutic platform for the development of microbial therapeutic leads
This profile is AI-generated and may contain inaccuracies.